You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 15, April 15, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Breast Cancer
 •Colon Cancer
 •Ovarian Cancer
 •Oncology, Other
 •Statistics and Research Methods
 •Endocrine Diseases
 •Diabetes Mellitus
 •Gastroenterology
 •Gastrointestinal Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Long-term Mortality in Cancer Patients With Preexisting Diabetes

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The meta-analysis by Dr Barone and colleagues1 showed that patients diagnosed with cancer who have preexisting diabetes are at increased risk for all-cause mortality compared with those without diabetes. We agree with this conclusion but have 2 comments. First, the study by Kouvaris et al2 included only 30 cancer patients with diabetes and 50 patients in total. Therefore, we wonder whether in Figure 2 the random-effects weight and the large data marker are correct.

Second, the authors discussed the possibility that patients with preexisting diabetes may present with later-stage disease. In our study of 5555 newly diagnosed cancer patients with diabetes, we found that they presented more often with later-stage colon, breast, or ovarian cancer than patients without diabetes.3 Adjustment for stage and treatment decreased the hazard ratio (HR) for overall mortality for women with ovarian cancer from 1.50 (95% confidence interval [CI], 1.16-1.93) to 1.31 (95% . . . [Full Text of this Article]

Lonneke van de Poll-Franse, PhD
l.vd.poll@ikz.nl

Jan Willem Coebergh, MD, PhD
Comprehensive Cancer Centre South
Eindhoven, the Netherlands



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus: A Systematic Review and Meta-analysis
Bethany B. Barone, Hsin-Chieh Yeh, Claire F. Snyder, Kimberly S. Peairs, Kelly B. Stein, Rachel L. Derr, Antonio C. Wolff, and Frederick L. Brancati
JAMA. 2008;300(23):2754-2764.
ABSTRACT | FULL TEXT  

RELATED LETTER

Long-term Mortality in Cancer Patients With Preexisting Diabetes—Reply
Bethany B. Barone, Hsin-Chieh Yeh, and Frederick L. Brancati
JAMA. 2009;301(15):1541.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.